About Karen Ginster
Form D filings for Fluidx Medical Technology from 2023 to 2024 list Karen Ginster as chief executive officer and director.
Karen Ginster first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Karen Ginster in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Karen Ginster works with at each company, as listed on that company's latest Form D.
Fluidx Medical Technology, Inc. · Form D/A, May 3, 2024